Clinical Trials on Metabolism and Nutrition Disorder

Total 158217 results

Nanjing Medical University

Not yet recruiting

Metabolites Profiling Reveals Nutrient Processing Patterns Upon Dietary Loading

Nutrition | Metabolism Disorder

China
Pennington Biomedical Research Center

Completed

Validity and Reliability of Commercially Available Metabolic Carts

Metabolism and Nutrition Disorder

United States
Ospedale San Donato
University of Milan

Completed

Metabolic and Functional Impact of Various Breakfast Models

Metabolism and Nutrition Disorder
Maastricht University

Completed

Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability

Metabolic Disturbance | Metabolism and Nutrition Disorder

Netherlands
Shandong Provincial Hospital

Recruiting

The Biological Rhythm of Human Metabolite

Metabolism and Nutrition Disorder | Rhythm Nodal | Metabolism Disorder, Lipid

China
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Recruiting

NUtrition and ORal Health in Orthopaedic Surgery

Orthopedic Disorder | Metabolism and Nutrition Disorder

Italy
Istituto Ortopedico Galeazzi

Recruiting

METabolism After Orthopedic Surgery

Orthopedic Disorder | Metabolism and Nutrition Disorder

Italy
Indiana University
American Society for Parenteral and Enteral Nutrition

Terminated

Prospective Evaluation of the Incidence of PICS (ProsPICS)

Metabolism and Nutrition Disorder

United States
Universitair Ziekenhuis Brussel
Baxter Healthcare Corporation; Nutricia, Inc.

Completed

Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN) (TiCaCONCO)

Metabolism and Nutrition Disorder

Belgium
Rabin Medical Center
Texas A&M University

Unknown

Amino Acid Metabolism in Fed Surgical Critically Ill Patients

Metabolism and Nutrition Disorder

Israel
Novo Nordisk A/S

Completed

In-market Utilisation of Liraglutide Used for Weight Management in Europe

Obesity | Metabolism and Nutrition Disorder

Italy, Germany
Novo Nordisk A/S

Completed

A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years

Obesity | Metabolism and Nutrition Disorder

Germany
Universitair Ziekenhuis Brussel

Completed

The CoCoS Interventional Trial: Caloric Control in Cardiac Surgery Patients

Metabolism and Nutrition Disorders
Mondelēz International, Inc.
University of Sydney

Completed

Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content and GI Consumed Alone.

Metabolism and Nutrition Disorders

Australia
University of Guelph
Advanced Orthomolecular Research

Completed

Clinical Investigation on the Safety of Avocado Pulp Lipids

Obesity | Overnutrition | Lipid Metabolism Disorders | Metabolic Disease | Nutritional Disorder | Avocado

Canada
Chinese Academy of Sciences
Sir Run Run Shaw Hospital

Recruiting

Lifestyle Intervention on Metabolic Homeostasis

Healthy | Obesity | Metabolism and Nutrition Disorder | Homeostasis

China
Novo Nordisk A/S

Completed

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

Obesity | Metabolism and Nutrition Disorder

Netherlands
Novo Nordisk A/S

Completed

Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors

Obesity | Metabolism and Nutrition Disorder

Germany
Benjamin Gollasch
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)...

Completed

Human Metabolic Dynamics at Rest and During Aerobic Exercise Under Normobaric Normoxic and Moderate Hypoxic Conditions

Hypoxia | Metabolism and Nutrition Disorder | Energy Metabolism

Germany
University of Kansas Medical Center

Not yet recruiting

Changes in Resting Metabolic Rate Following Orthopedic Surgery

Resting Metabolic Rate | Post Operative Nutrition | Metabolism; Disorder, Postprocedural
Novo Nordisk A/S

Completed

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.

Obesity | Metabolism and Nutrition Disorder

Denmark
Novo Nordisk A/S

Completed

Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects

Obesity | Metabolism and Nutrition Disorder

United States
Ospedale San Donato

Completed

Use of Indirect Calorimetry in Obesity

Overweight and Obesity | Metabolism Disorder

Italy
Novo Nordisk A/S

Completed

Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects

Obesity | Metabolism and Nutrition Disorder

United States
University of Palermo

Completed

Health Effects of Biostimulated Lettuce in Human (NUTRIWEED23)

Glucose Metabolism Disorders | Bone Resorption | Hepatic Steatosis | Nutrition, Healthy | Dietary Deficiency | Lipid Metabolism Disorder

Italy
Novo Nordisk A/S

Completed

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

Obesity | Metabolism and Nutrition Disorder

United States, Israel, Russian Federation, United Kingdom, Canada, Belgium, Germany, Australia
Novo Nordisk A/S

Terminated

Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Withdrawn

Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers

Obesity | Metabolism and Nutrition Disorder
Novo Nordisk A/S

Completed

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Terminated

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting (SCALE™ IBT)

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Awareness, Care & Treatment in Obesity Management (ACTION) Study (ACTION)

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Awareness, Care and Treatment in Obesity Management

Obesity | Metabolism and Nutrition Disorder

Canada
Novo Nordisk A/S

Completed

Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight

Obesity | Metabolism and Nutrition Disorder

United States
University of Calgary
Natural Sciences and Engineering Research Council, Canada

Withdrawn

Metabolic and Genetic Impacts of Energy Drinks in Youth

Pediatric Obesity | Glucose Intolerance | Health Behavior | Nutrition | Caffeine | Pediatric | Metabolism Disorder, Glucose

Canada
University of Wisconsin, Madison
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

How Does Magnesium Status Influence Calcium Homeostasis?

Calcium Metabolism Disorders | Magnesium Deficiency

United States
Novo Nordisk A/S

Completed

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (STEP 4)

Obesity | Metabolism and Nutrition Disorder

United States, Israel, Spain, Netherlands, Sweden, Switzerland, South Africa, Denmark, Portugal, Ukraine
Novo Nordisk A/S

Completed

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

Obesity | Metabolism and Nutrition Disorder

United States, Russian Federation, Sweden, Belgium, Mexico
Taipei Medical University WanFang Hospital

Unknown

The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient

Malnutrition | Hyperphosphatemia

Taiwan
Laval University

Completed

Duodenal Switch With a Standard Versus Long Alimentary Limb (Long_limb_DS)

Obesity, Morbid | Bariatric Surgery Candidate | Metabolism Disorder
University of Aberdeen

Completed

Modified Whey Protein and Effect on Post Meal Glucose Levels Study (MWPS)

Metabolism Disorder, Glucose

United Kingdom

Clinical Trials on Metabolism and Nutrition Disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations